Posted in | News | Photovoltaics

Imomec and Solliance Present CZTSe-Based Solar Cell at Intersolar Conference

At next week’s Intersolar conference in San Francisco, imomec, imec’s associated lab at the Hasselt University, and Solliance, the European R&D consortium that focuses on thin-film photovoltaic solar energy (PV), will present a CZTSe (Cu2ZnSnSe4)-based solar cell with 9.7 percent efficiency (1x1cm2, AM1.5G).

Thin-film CZTSe solar cell achieving 9.7% efficiency

This promising result is an important step bringing the solar industry closer to a sustainable alternative for the highest efficiency thin-film solar cells in production, based on CIGS (Cu(In,Ga)(S,Se)2).

CZTSe is an emerging alternative solar cell absorber in thin-film solar cells, similar to CZTS (Cu2ZnSnS4). Unlike CIGS, CZTS and CZTSe do not suffer from abundancy issues. At 1.5-1.6eV for CZTS, and 0.9eV for CZTSe, their bandgaps make a combined material system ideal for a multi-junction, thin-film solar cell that rivals the efficiency of CIGS cells (about 20 percent). Imomec, imec and Solliance have defined a path towards further improving the layers and cell structures of CZTSe and CZTS absorbers aiming at developing a multi junction CZTS/CZTSe solar cell with 20 percent cell efficiency. The presented CZTSe solar cell is an important step forward to reach this goal.

Imec/imomec fabricated the CZTSe layers by sputtering Cu, Zn and Sn metal layers on a Molybdenum-on-glass substrate and subsequent annealing in an H2Se containing atmosphere, achieving 9.7 percent efficiency. The resulting polycrystalline absorber layers are only 1µm thick, with a typical grain size of about 1µm. The samples were then processed at Helmholtz Zentrum Berlin into solar cells using a standard process flow for thin film solar cells and finished with a metal grid and anti-reflective coating at imec. The highest efficiency obtained on a
1x1cm2 cell was 9.7 percent, with a maximum short circuit current of 38.9mA/cm2, an open circuit voltage of 0.41V and a fill factor of 61 percent.

“This is a big win for us. We’ve been working toward this milestone since 2011 when we first started our research on alternative materials for thin-film photovoltaics at imec/imomec,” said Marc Meuris, program manager Solliance of the alternative thin-film PV program. “Our efficiencies are the highest in Europe and approaching the world record for this type of thin-film solar cells, and we look forward to further advancing R&D to help bringing to market sustainable energy sources.”

The sputtering of the Cu, Zn, Sn layers was performed at Flamac (Gent), and the international glass manufacturer AGC delivered Molybdenum-on- glass substrates. Imec’s thin-film solar cell activities at imomec (imec’s associated laboratory at the university of Hasselt) are integrated in the Solliance cross-border collaboration platform, and the research was partially supported by the Flemish ‘Strategisch Initiatief Materialen’ (SIM) SoPPoM program.

*certification expected in October 2013.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    IMEC. (2019, February 09). Imomec and Solliance Present CZTSe-Based Solar Cell at Intersolar Conference. AZoM. Retrieved on April 24, 2024 from https://www.azom.com/news.aspx?newsID=37393.

  • MLA

    IMEC. "Imomec and Solliance Present CZTSe-Based Solar Cell at Intersolar Conference". AZoM. 24 April 2024. <https://www.azom.com/news.aspx?newsID=37393>.

  • Chicago

    IMEC. "Imomec and Solliance Present CZTSe-Based Solar Cell at Intersolar Conference". AZoM. https://www.azom.com/news.aspx?newsID=37393. (accessed April 24, 2024).

  • Harvard

    IMEC. 2019. Imomec and Solliance Present CZTSe-Based Solar Cell at Intersolar Conference. AZoM, viewed 24 April 2024, https://www.azom.com/news.aspx?newsID=37393.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.